Paediatric Immunology and Allergy

Uzm. Dr. Burcu Kolukısa

Doctor and researcher Kartal Dr. Lütfi Kırdar Şehir Hastanesi İstanbul
Primary Immunodeficiency DiseasesImmunologic Deficiency Syndromes
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Primary Immunodeficiency Diseases 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Immunologic Deficiency Syndromes 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPaediatric Immunology and Allergysaglik.gov.trFrom source
  • Department name at the sourceÇocuk İmmünolojisi ve Allerji Hastalıklarısaglik.gov.trFrom source
  • InstitutionKartal Dr. Lütfi Kırdar Şehir Hastanesisaglik.gov.trFrom source
  • Area of workPrimary Immunodeficiency DiseasesExtracted from 5 publications · Model version —From source
  • Publications17 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-2399-8630ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://lutfikirdareah.saglik.gov.tr/TR-1480000/doktorlarimiz.html#burcu-kolukisasaglik.gov.tr

Scientific work

Publications on Primary Immunodeficiency Diseases

17 publications

  1. Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity

    Journal of Clinical Immunology, 2026

    DOI 10.1007/s10875-025-01972-1 PMID 41493669 Open-access full textSource: OpenAlex

  2. Early-Life Wheezing and Atopic Burden Are Associated with Treatment-Defined Asthma Severity and Control in School-Age Children: A Two-Center Cross-Sectional Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166459 PMID 42652863 Open-access full textSource: ORCID

  3. Algorithms in Allergy: Elevated IgE in Pediatric Patients

    Allergy, 2026

    DOI 10.1111/all.70376 PMID 42083109 Source: ORCID

  4. A plain language summary of a study looking at the effects of pozelimab in children with CHAPLE disease

    Future Rare Diseases, 2025

    DOI 10.1080/23995270.2025.2498826 Open-access full textSource: OpenAlex

  5. Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

    The Lancet, 2024

    DOI 10.1016/s0140-6736(23)02358-9 PMID 38278170 26 citations (Europe PMC) Open-access full textSource: ORCID

  6. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome

    Journal of Clinical Immunology, 2024

    DOI 10.1007/s10875-023-01620-6 PMID 38129713 10 citations (Europe PMC) Source: ORCID

  7. A Phase 2/3 Study Evaluating the Efficacy and Safety of Pozelimab in Patients with CD55 Deficiency with Hyperactivation of Complement, Angiopathic Thrombosis, and Protein-Losing Enteropathy (CHAPLE Disease)

    SSRN, 2023

    DOI 10.2139/ssrn.4485593 Source: ORCID

  8. Human carmil2 deficiency underlies a broader immunological and clinical phenotype than cd28 deficiency

    Journal of Experimental Medicine, 2023

    DOI 10.1084/jem.20220275 PMID 36515678 34 citations (Europe PMC) Open-access full textSource: ORCID

  9. 25 A phase 2/3 study evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE disease)

    Immunobiology, 2023

    DOI 10.1016/j.imbio.2023.152482 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency

    Journal of Clinical Immunology, 2022

    DOI 10.1007/s10875-021-01191-4 PMID 35079916 35 citations (OpenAlex) Open-access full textSource: OpenAlex

View all 17 publications